Cargando…
Unusual Presentation of Acute Perimyocarditis Following SARS-COV-2 mRNA-1237 Moderna Vaccination
Since the start of the pandemic, to date, around 180 million cases have been diagnosed with COVID-19 worldwide with an estimated 3.9 million death toll. Mass vaccination has taken place to control spread of infection with the most commonly used vaccines being Pfizer-BioNTech and Moderna. However, th...
Autores principales: | Khogali, Fatima, Abdelrahman, Rabab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381757/ https://www.ncbi.nlm.nih.gov/pubmed/34447639 http://dx.doi.org/10.7759/cureus.16590 |
Ejemplares similares
-
Perimyocarditis: An Unusual Manifestation of Dengue Virus Infection
por: Ullah, Assam, et al.
Publicado: (2023) -
Biventricular Takotsubo Cardiomyopathy as an Unusual Presentation of SARS-CoV-2 mRNA Vaccine-Associated Multisystemic Inflammatory Syndrome
por: Arellano-Arteaga, Kevin J., et al.
Publicado: (2023) -
Retinal Vein Occlusion Following Two Doses of mRNA-1237 (Moderna) Immunization for SARS-Cov-2: A Case Report
por: Sacconi, Riccardo, et al.
Publicado: (2021) -
Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report
por: Hasnie, Ammar A., et al.
Publicado: (2021) -
Toxic Epidermal Necrolysis after COVID-19 mRNA-1237 Vaccination
por: Hehr, Nicole, et al.
Publicado: (2023)